Some oncologists are turning to GLP-1 agents to help patients shed excess pounds, with the goal of improving cancer outcomes.

Roche told investors on Monday that it plans to make significant cuts to both the cost and time it takes for it to develop ...

WeightWatchers announced the departure of CEO Sima Sistani, effective immediately, and board member Tara Comonte, former ...

In a leadership shakeup, the diet company says CEO Sima Sistani would leave her role effective immediately. Tara Comonte, a ...

On Tuesday, congressional leaders spent two hours taking to task Novo Nordisk Chief Executive Officer Lars Fruergaard Jørgensen over the high price of the company’s diabetes and obesity drugs, Ozempic ...

Weight loss drugs are rising in popularity. Savannah doctors weigh in on risks and benefits ...

Two naturally occurring molecules could be the key to sustained weight management, offering an organic alternative to ...

Discover the revival of the biotech sector, with IPOs resurging and promising weight loss drug potential, despite facing ...

Semaglutide, sold as Wegovy and Ozempic, may reduce opioid overdoses in people with opioid-use disorder and type 2 diabetes.

Tom Arnold revealed how he lost 80 pounds without taking Ozempic. Arnold began working with fitness guru Charles D'Angelo in ...

Real-time index price for Dow Jones Transportations Average (DOWT), along with buy or sell indicators, analysis, charts, historical performance, news and more ...

Roche said on Monday that three early-stage obesity and diabetes drug candidates from its acquisition of Carmot Therapeutics ...